The Applied Research Institute, Inc. (“ARI”) announced the U.S. Department of Commerce Economic Development Administration has designated Heartland BioWorks as a Regional Technology and Innovation Hub. Heartland BioWorks will now compete against other designated hubs for implementation grants of up to $75 million each later this year.
The Regional Tech Hub designation, and the funding that follows, will support the acceleration of workforce development and help dismantle barriers to success for entrepreneurs and small business owners with new biotech products.
Led by the Applied Research Institute, Heartland BioWorks is a consortium of Indiana stakeholders driven by strong collaborative innovation practices to ensure that bioproducts invented in America are also produced domestically. Indiana’s Indianapolis-Carmel-Anderson metropolitan statistical area features the unmatched collection of resources and capabilities necessary to become the world-leading force that secures our nation’s biomanufacturing future. The region is home to landmark industry leaders that span the bioecosystem; R1 institutions focused on biotechnology and manufacturing innovations; coordinated state-regional-local prioritization of life sciences to advance economic opportunities; a rapidly growing venture ecosystem; and significant biotech investment momentum.
“The Economic Development Administration, with this designation, confirms what we here in Indiana have known for a long time—that the Hoosier state is a global pioneer in biotech production,” said Applied Research Institute Chief Executive Officer Dave Roberts. “Heartland BioWorks is securing America’s biotech future, and this Hub will provide biotech startups with access to manufacturing facilities and expertise, implement the workforce training future biotech innovations require, and focus on engaging innovators in historically underserved communities.”
“When I authored the Regional Technology and Innovation Hubs program, my goal was to spur more innovation in technologies of the future in places like Indiana, rather than just Silicon Valley and a few coastal cities,” said Indiana Senator Todd Young. “Today’s announcement to designate Heartland Bioworks as a Tech Hub is a recognition of Indiana’s leadership in biotechnology and synthetic biology research and manufacturing, and another major win for Hoosiers. This designation could lead to millions in federal investment and will open the floodgates for more private capital in biotech R&D across the state.”
“This is just the news we hoped to receive. The EDA’s designation of Heartland BioWorks as a Regional Tech Hub is a recognition of Indiana’s rich tradition of innovation and leadership in both the manufacturing and life science sectors,” said Indiana Governor Eric J. Holcomb. “We‘ll continue to strongly support the Hub and look forward to moving forward in the process.”
“This new Tech Hub designation is yet another win for Indiana as we work to foster and cultivate the industries of tomorrow,” said Indiana Secretary of Commerce David Rosenberg. “Heartland BioWorks’ multifaceted approach to advancing biotechnology and biomanufacturing will nurture industry-specific startups, investments and R&D, driving life-changing products and life-saving solutions leveraged across the world. This will also create profound opportunities for our state’s brightest minds to innovate and collaborate, while cementing the U.S. and Indiana as the leading hub for biotech manufacturing.”
“Today’s announcement is another step toward Central Indiana leading the country in innovation and unlocking the opportunity to bring millions of dollars in Federal funding to achieve those goals,” said Central Indiana Regional Development Authority executive director Jennifer Messer. “CIRDA’s collaboration with and support of ARI to secure this designation will impact the Central Indiana region for decades to come.”
“As Fishers grows its foothold in the life science industry, it’s critical that we tap into every resource available to reinvest in key sectors, workforce, and innovation,” remarked Fishers Mayor Scott Fadness. “Today’s announcement opens up the possibilities we’ve been working toward and we look forward to collaborating with ARI and our collaboration partners to execute on this opportunity.”
“As the birthplace of the historic, world pharmaceutical giant Eli Lilly & Co., and as the recipient of more than $1.5 billion in new biotech investment in under a decade, Indianapolis has an attractive portfolio in this field,” said Indianapolis Mayor Joe Hogsett. “That was why the City of Indianapolis was proud to join and advocate on behalf of Heartland BioWorks. The news of the Regional Tech Hub designation represents enormous potential for employability and prosperity in Indianapolis.”
Indiana stakeholders have described the need for more dedicated manufacturing operations and innovation space. The Regional Tech Hubs program will catalyze further production, which will foster innovation and encourage more businesses to start and grow in Indiana.
Heartland BioWorks will initially focus on three integrated activities that address “biotechnology, medical technology, genomics, and synthetic biology” gaps identified by the Economic Development Administration in both the region and nation. Those three include the BioWorks Training Institute, the BioWorks Bioproduct Launch Network, and the BioWorks Advanced Manufacturing Innovation Network.
